Skip to main
LLY
LLY logo

Eli Lilly (LLY) Earnings Dates & Reports

Eli Lilly (LLY) Most Recent Earnings

Report DateMay 1, 2025
Period EndingQ1 2025
Est. EPS$3.02
Actual EPS$3.34
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Eli Lilly (LLY) Earnings per Share (EPS) History

Signup for full access
Browse free

Eli Lilly (LLY) Latest Earnings

The value each LLY share was expected to gain vs. the value each share gained.

Eli Lilly (LLY) reported its most recent earnings on May 1, 2025 for Q1 2025, posting earnings per share (EPS) of $3.34. This exceeded analysts' expectations of $3.02 by 10.60%, marking a Beat.

For comparison, Eli Lilly reported EPS of $2.58 in the same quarter last year.

The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of $5.55.

Eli Lilly (LLY) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 7, 2025
$5.55Next earnings call Aug. 7, 2025
Q1 2025May 1, 2025
$3.02$3.34+10.60%
DeckReportListen
Q4 2024Feb 6, 2025
$5.08$5.32+4.72%
Q3 2024Oct 30, 2024
$1.45$1.18-18.62%
Q2 2024Aug 8, 2024
$2.70$3.92+45.19%
View all

Eli Lilly (LLY) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Eli Lilly’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 1, 2025
Feb 6, 2025
Oct 30, 2024
Aug 8, 2024

Eli Lilly (LLY) Earnings FAQs

Eli Lilly (LLY) last reported earnings on May 1, 2025 for Q1 2025, posting an EPS of $3.34, which Beat the estimate of $3.02 by 10.60%.

For Q1 2025, Eli Lilly (LLY) reported an EPS of $3.34, exceeding analysts' estimate of $3.02 by 10.60%.

For Q1 2025, Eli Lilly (LLY) Beat expectations with an actual EPS of $3.34 vs. an estimated EPS of $3.02.

Following the last earnings report on May 1, 2025, Eli Lilly (LLY)'s stock price moved — from — to —.

The next Eli Lilly (LLY) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.

Eli Lilly (LLY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.